Promoter polymorphism in the 5‐lipoxygenase (ALOX5) and 5‐lipoxygenase‐activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population
Ian Sayers(University of Leicester), Stephen T. Holgate(University of Southampton), John W. Holloway(University of Southampton), Bianca Beghé(Azienda Ospedaliero-Universitaria di Modena), Sheila J. Barton(University Hospital Southampton NHS Foundation Trust), Anthony P. Sampson(Southampton General Hospital), Tim P. Keith(NKT Therapeutics (United States)), J. E. Sawyer, Steuart Rorke(University of Southampton), Shu Ye(Shantou University), Joanne Clough(University of Southampton), Qiuju Peng
Cited by 57
Related Papers
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults
|Journal of the American College of Cardiology|2018|832
Treatment strategies for allergy and asthma
|Nature reviews. Immunology|2008|687
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
Genome-wide association study identifies five loci associated with lung function
|Nature Genetics|2009|598